This is a Phase 2 study evaluating how UBT251 affects blood sugar, body weight, and heart health.

This is a Phase 3 study assessing how zenagamtide affects blood sugar levels and body weight.

This is a Phase 3 study assessing how zenagamtide affects blood sugar levels and body weight.

This is a Phase 3 study evaluating how retatrutide and tirzepatide (Zepbound) may slow the progression of high-risk metabolic fatty liver disease (MASLD) and help prevent serious liver complications.

This is a Phase 2 study evaluating how clofutriben may affect blood sugar control (HbA1c) and metabolic health.

This is a study and we’ll need to provide a once sentence blurb here.